GDF2 and hereditary hemorrhagic telangiectasia: More recently, an “HHT-like” phenotype has been described in individuals with mutations in GDF2, encoding BMP9, but it is unclear whether the phenotype of these patients should be clinically categorized as HHT [7,8,9,10,11].